8-K Announcements
6Material company update
Apr 23, 2026·SEC
Material company update
Apr 13, 2026·SEC
Material company update
Feb 25, 2026·SEC
Chemed Corporation(CHE)Earnings, Financials & Key Ratios
CHE•NYSE
23.7× P/E·Price updated Jun 19, 2026
AboutChemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Show more
- Revenue$2.53B+4.1%
- EBITDA$403M-6.2%
- Net Income$265M-12.2%
- EPS (Diluted)18.42-7.4%
- Gross Margin29.97%-14.7%
- EBITDA Margin15.93%-9.8%
- Operating Margin13.37%-11.3%
- Net Margin10.48%-15.6%
- ROE25.28%-6.8%
CHE Key Insights
Chemed Corporation (CHE) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 27.0%
- ✓17 consecutive years of dividend growth
- ✓High quality earnings: Operating CF exceeds net income
- ✓Share count reduced 5.2% through buybacks
- ✓Healthy 5Y average net margin of 11.8%
- ✓Efficient asset utilization: 1.5x turnover
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CHE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CHE Price & Volume
Chemed Corporation (CHE) stock price & volume — 10-year historical chart
Loading chart...
CHE Growth Metrics
Chemed Corporation (CHE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years5.07%
5 Years4%
3 Years5.82%
TTM2.07%
Profit CAGR
10 Years9.17%
5 Years-3.65%
3 Years2.04%
TTM-15.86%
EPS CAGR
10 Years11.27%
5 Years-1.11%
3 Years3.67%
TTM-10.66%
Return on Capital
10 Years28.06%
5 Years28.34%
3 Years26.24%
Last Year24.73%
CHE Recent Earnings
Chemed Corporation (CHE) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
Apr 23, 2026Metric
Actual
Est
EPS
$5.65+6.6%
$5.30
Rev
$658M+1.2%
$650M
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$6.42-8.5%
$7.02
Rev
$639M-3.0%
$659M
Q4 2025
Oct 28, 2025Metric
Actual
Est
EPS
$5.27-2.2%
$5.39
Rev
$625M-5.2%
$659M
Q3 2025
Jul 29, 2025Metric
Actual
Est
EPS
$4.27-10.7%
$4.78
Rev
$619M-2.0%
$631M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 23, 2026 | $5.65vs $5.30+6.6% | $658Mvs $650M+1.2% |
| Q1 2026 | Feb 25, 2026 | $6.42vs $7.02-8.5% | $639Mvs $659M-3.0% |
| Q4 2025 | Oct 28, 2025 | $5.27vs $5.39-2.2% | $625Mvs $659M-5.2% |
| Q3 2025 | Jul 29, 2025 | $4.27vs $4.78-10.7% | $619Mvs $631M-2.0% |
Based on last 12 quarters of dataView full earnings history →
CHE Peer Comparison
Chemed Corporation (CHE) competitors in Home-based care services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ADUS | 1.76B | 94.23 | 18.09 | 23.21% | 6.89% | 9.34% | 0.19 | |
 ENSG | 8.98B | 153.65 | 26.31 | 18.72% | 6.89% | 16.61% | 1.86 | |
 SCI | 10.07B | 72.62 | 19.11 | 2.93% | 14.46% | 39.44% | 3.14 | |
 CSV | 605.26M | 38.16 | 11.74 | 3.28% | 10.56% | 17.6% | 2.21 | |
 HCSG | 1.64B | 22.94 | 28.32 | 7.08% | 3.21% | 11.83% | 0.05 | |
 OPCH | 3.44B | 21.99 | 17.32 | 13.03% | 3.64% | 15.28% | ||
 UNH | 363.94B | 400.96 | 30.31 | 11.81% | 2.68% | 11.54% | 0.77 | |
 HUM | 43.3B | 360.65 | 36.65 | 10.06% | 0.82% | 6.17% | 0.73 |
Compare CHE vs Peers
Chemed Corporation (CHE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CHE Income Statement
Chemed Corporation (CHE) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 1.67B | 1.78B | 1.94B | 2.08B | 2.14B | 2.13B | 2.26B | 2.43B | 2.53B | 2.54B |
Revenue Growth % | 5.7% | 6.96% | 8.75% | 7.27% | 2.87% | -0.2% | 6.06% | 7.37% | 4.06% | 2.07% |
Cost of Goods Sold | 1.15B | 1.23B | 1.32B | 1.38B | 1.37B | 1.37B | 1.47B | 1.58B | 1.77B | 1.31B |
COGS % of Revenue | 69.03% | 68.87% | 68.15% | 66.27% | 64.02% | 64.16% | 64.72% | 64.86% | 70.03% | - |
Gross Profit | 516.19M▲ 0% | 555M▲ 7.5% | 617.43M▲ 11.2% | 701.39M▲ 13.6% | 769.8M▲ 9.8% | 765.09M▼ 0.6% | 798.82M▲ 4.4% | 854.35M▲ 7.0% | 758.34M▼ 11.2% | 571.36M▲ 0% |
Gross Margin % | 30.97% | 31.13% | 31.85% | 33.73% | 35.98% | 35.84% | 35.28% | 35.14% | 29.97% | 22.49% |
Gross Profit Growth % | 11.86% | 7.52% | 11.25% | 13.6% | 9.75% | -0.61% | 4.41% | 6.95% | -11.24% | - |
Operating Expenses | 403.16M | 311.37M | 360.05M | 311.71M | 426.76M | 421.59M | 458.25M | 487.86M | 417.19M | 442.21M |
OpEx % of Revenue | 24.19% | 17.47% | 18.57% | 14.99% | 19.95% | 19.75% | 20.24% | 20.07% | 16.49% | - |
Selling, General & Admin | 276.65M | 271.21M | 305.71M | 330.22M | 366.73M | 358.73M | 395.12M | 424.36M | 417.19M | 425M |
SG&A % of Revenue | 16.6% | 15.21% | 15.77% | 15.88% | 17.14% | 16.8% | 17.45% | 17.45% | 16.49% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 126.5M | 40.16M | 54.34M | -18.51M | 60.04M | 62.86M | 63.13M | 63.49M | 0 | 1000K |
Operating Income | 113.03M▲ 0% | 243.63M▲ 115.5% | 257.38M▲ 5.6% | 389.68M▲ 51.4% | 343.04M▼ 12.0% | 343.5M▲ 0.1% | 340.57M▼ 0.9% | 366.49M▲ 7.6% | 338.25M▼ 7.7% | 328.07M▲ 0% |
Operating Margin % | 6.78% | 13.67% | 13.28% | 18.74% | 16.04% | 16.09% | 15.04% | 15.07% | 13.37% | 12.91% |
Operating Income Growth % | -36.76% | 115.54% | 5.64% | 51.4% | -11.97% | 0.13% | -0.85% | 7.61% | -7.71% | - |
EBITDA | 148.66M | 282.5M | 302.58M | 446.26M | 402.09M | 402.67M | 401.43M | 429.54M | 403.09M | 376.89M |
EBITDA Margin % | 8.92% | 15.85% | 15.61% | 21.46% | 18.8% | 18.86% | 17.73% | 17.67% | 15.93% | 14.84% |
EBITDA Growth % | -30.33% | 90.03% | 7.11% | 47.48% | -9.9% | 0.14% | -0.31% | 7% | -6.16% | -16.65% |
D&A (Non-Cash Add-back) | 35.63M | 38.86M | 45.2M | 56.58M | 59.05M | 59.17M | 60.87M | 63.05M | 64.84M | 48.82M |
EBIT | 121.19M | 244.59M | 266.14M | 398.35M | 352.18M | 334.26M | 353.48M | 401.25M | 357.53M | 263.07M |
Net Interest Income | -3.85M | -4.32M | -4.02M | -1.6M | -1.49M | -4.23M | 3.16M | 12.83M | 7M | 5.78M |
Interest Income | 427K | 671K | 513K | 757K | 377K | 355K | 6.27M | 14.61M | 8.74M | 9.63M |
Interest Expense | 4.27M | 4.99M | 4.54M | 2.35M | 1.87M | 4.58M | 3.11M | 1.78M | 1.75M | 2.45M |
Other Income/Expense | 3.88M | -4.03M | 4.23M | 6.31M | 7.28M | -13.82M | 9.8M | 32.97M | 17.53M | 20.88M |
Pretax Income | 116.92M▲ 0% | 239.6M▲ 104.9% | 261.61M▲ 9.2% | 395.99M▲ 51.4% | 350.31M▼ 11.5% | 329.68M▼ 5.9% | 350.37M▲ 6.3% | 399.46M▲ 14.0% | 355.78M▼ 10.9% | 348.94M▲ 0% |
Pretax Margin % | 7.01% | 13.44% | 13.5% | 19.04% | 16.38% | 15.44% | 15.47% | 16.43% | 14.06% | 13.73% |
Income Tax | 18.74M | 34.06M | 41.69M | 76.52M | 81.76M | 80.06M | 77.86M | 97.47M | 90.54M | 89.16M |
Effective Tax Rate % | 16.03% | 14.21% | 15.93% | 19.32% | 23.34% | 24.28% | 22.22% | 24.4% | 25.45% | 25.55% |
Net Income | 98.18M▲ 0% | 205.54M▲ 109.4% | 219.92M▲ 7.0% | 319.47M▲ 45.3% | 268.55M▼ 15.9% | 249.62M▼ 7.0% | 272.51M▲ 9.2% | 302M▲ 10.8% | 265.24M▼ 12.2% | 259.78M▲ 0% |
Net Margin % | 5.89% | 11.53% | 11.34% | 15.36% | 12.55% | 11.69% | 12.03% | 12.42% | 10.48% | 10.23% |
Net Income Growth % | -9.72% | 109.36% | 7% | 45.26% | -15.94% | -7.05% | 9.17% | 10.82% | -12.17% | -15.86% |
Net Income (Continuing) | 98.18M | 205.54M | 219.92M | 319.47M | 268.55M | 249.62M | 272.51M | 302M | 265.24M | 259.78M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 5.86▲ 0% | 12.23▲ 108.7% | 13.31▲ 8.8% | 19.48▲ 46.4% | 16.85▼ 13.5% | 16.53▼ 1.9% | 17.93▲ 8.5% | 19.89▲ 10.9% | 18.42▼ 7.4% | 19.00▲ 0% |
EPS Growth % | -9.57% | 108.7% | 8.83% | 46.36% | -13.5% | -1.9% | 8.47% | 10.93% | -7.39% | -10.66% |
EPS (Basic) | 6.11 | 12.80 | 13.77 | 20.02 | 17.14 | 16.72 | 18.11 | 20.10 | 18.42 | - |
Diluted Shares Outstanding | 16.74M | 16.8M | 16.53M | 16.4M | 15.94M | 15.1M | 15.2M | 15.19M | 14.4M | 13.68M |
Basic Shares Outstanding | 16.06M | 16.06M | 15.97M | 15.96M | 15.67M | 14.93M | 15.05M | 15.02M | 14.4M | 13.68M |
Dividend Payout Ratio | 17.69% | 9.08% | 9% | 6.6% | 8.2% | 8.82% | 8.62% | 8.97% | 11.95% | - |
CHE Balance Sheet
Chemed Corporation (CHE) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 176.05M | 159.84M | 190.67M | 329.4M | 230.29M | 272.61M | 500.84M | 394.75M | 302.62M | 274.06M |
Cash & Short-Term Investments | 11.12M | 4.83M | 6.16M | 162.68M | 32.9M | 74.13M | 263.96M | 178.35M | 74.52M | 16.86M |
Cash Only | 11.12M | 4.83M | 6.16M | 162.68M | 32.9M | 74.13M | 263.96M | 178.35M | 74.52M | 16.86M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 113.65M | 119.5M | 143.83M | 126.85M | 137.22M | 139.41M | 181.51M | 171.16M | 182.57M | 215.48M |
Days Sales Outstanding | 24.89 | 24.47 | 27.08 | 22.26 | 23.41 | 23.83 | 29.26 | 25.7 | 26.34 | 28.68 |
Inventory | 5.33M | 5.71M | 7.46M | 7.09M | 10.11M | 10.27M | 12M | 8.19M | 7.54M | 7.21M |
Days Inventory Outstanding | 1.69 | 1.7 | 2.06 | 1.88 | 2.69 | 2.74 | 2.99 | 1.9 | 1.55 | 2.24 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34.52M |
Total Non-Current Assets | 743.98M | 815.69M | 1.08B | 1.11B | 1.11B | 1.17B | 1.17B | 1.27B | 1.34B | 1.26B |
Property, Plant & Equipment | 143.03M | 162.03M | 287.42M | 311.27M | 318.73M | 335.38M | 330.23M | 328.16M | 336.81M | 133.6M |
Fixed Asset Turnover | 11.65x | 11.00x | 6.74x | 6.68x | 6.71x | 6.37x | 6.86x | 7.41x | 7.51x | 8.94x |
Goodwill | 476.89M | 510.57M | 577.37M | 578.59M | 578.59M | 581.29M | 585.02M | 666.74M | 667M | 687.5M |
Intangible Assets | 54.87M | 68.25M | 126.37M | 118.08M | 108.1M | 99.73M | 90.26M | 92.21M | 82.76M | 80.42M |
Long-Term Investments | 62.07M | 65.62M | 77.45M | 88.81M | 98.88M | 0 | 0 | 0 | 140.35M | 284.13M |
Other Non-Current Assets | 7.13M | 9.21M | 9.05M | 8.76M | 8.14M | 153M | 161.74M | 186.72M | 8.65M | 216.46M |
Total Assets | 920.03M▲ 0% | 975.53M▲ 6.0% | 1.27B▲ 30.0% | 1.43B▲ 13.1% | 1.34B▼ 6.4% | 1.44B▲ 7.4% | 1.67B▲ 15.7% | 1.67B▲ 0.0% | 1.64B▼ 1.7% | 1.54B▲ 0% |
Asset Turnover | 1.81x | 1.83x | 1.53x | 1.45x | 1.59x | 1.48x | 1.36x | 1.46x | 1.54x | 1.56x |
Asset Growth % | 4.54% | 6.03% | 30.01% | 13.13% | -6.42% | 7.39% | 15.68% | 0.03% | -1.71% | -21.99% |
Total Current Liabilities | 193.52M | 191.67M | 262.22M | 299.11M | 302.4M | 297.2M | 312.05M | 285.69M | 287.13M | 321.42M |
Accounts Payable | 48.37M | 50.15M | 51.1M | 54.23M | 73.02M | 41.88M | 64.03M | 44.15M | 53.46M | 65.7M |
Days Payables Outstanding | 15.35 | 14.91 | 14.12 | 14.36 | 19.46 | 11.16 | 15.95 | 10.22 | 11.01 | 15.17 |
Short-Term Debt | 10M | 0 | 0 | 0 | 0 | 5M | 15.7M | 0 | 51.89M | 41.29M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 86.4M | 93.57M | 114.44M | 133.88M | 134.63M | 145.84M | 121.87M | 134.75M | 120.95M | 280.13M |
Current Ratio | 0.91x | 0.83x | 0.73x | 1.10x | 0.76x | 0.92x | 1.61x | 1.38x | 1.05x | 0.85x |
Quick Ratio | 0.88x | 0.80x | 0.70x | 1.08x | 0.73x | 0.88x | 1.57x | 1.35x | 1.03x | 0.83x |
Cash Conversion Cycle | 11.24 | 11.25 | 15.02 | 9.78 | 6.64 | 15.41 | 16.3 | 17.37 | 16.88 | 15.74 |
Total Non-Current Liabilities | 186.15M | 192.53M | 279.49M | 234.6M | 417.05M | 346.09M | 248.17M | 263.89M | 373.48M | 366.41M |
Long-Term Debt | 91.2M | 89.2M | 90M | 0 | 185M | 92.5M | 0 | 0 | 0 | 195.65M |
Capital Lease Obligations | -61.8M | 0 | 86.66M | 99.21M | 100.63M | 110.51M | 100.78M | 98.54M | 102.87M | 304.19M |
Deferred Tax Liabilities | 16.64M | 21.6M | 18.5M | 20.66M | 23.18M | 38.61M | 30.32M | 25.95M | 121.14M | 158.1M |
Other Non-Current Liabilities | 78.31M | 81.73M | 84.33M | 114.73M | 108.24M | 104.47M | 117.07M | 139.4M | 13.34M | 156.18M |
Total Liabilities | 379.67M | 384.19M | 541.71M | 533.71M | 719.45M | 643.3M | 560.22M | 549.58M | 660.61M | 687.82M |
Total Debt | 101.2M | 89.2M | 215.94M | 135.41M | 323.54M | 247.01M | 155.11M | 140.84M | 154.76M | 236.93M |
Net Debt | 90.08M | 84.37M | 209.78M | -27.27M | 290.65M | 172.88M | -108.85M | -37.51M | 80.24M | 220.08M |
Debt / Equity | 0.19x | 0.15x | 0.30x | 0.15x | 0.52x | 0.31x | 0.14x | 0.13x | 0.16x | 0.28x |
Debt / EBITDA | 0.68x | 0.32x | 0.71x | 0.30x | 0.80x | 0.61x | 0.39x | 0.33x | 0.38x | 0.63x |
Net Debt / EBITDA | 0.61x | 0.30x | 0.69x | -0.06x | 0.72x | 0.43x | -0.27x | -0.09x | 0.20x | 0.58x |
Interest Coverage | 28.37x | 49.02x | 58.69x | 169.15x | 188.53x | 72.92x | 113.73x | 225.42x | 204.30x | 107.24x |
Total Equity | 540.35M▲ 0% | 591.33M▲ 9.4% | 726.61M▲ 22.9% | 901.2M▲ 24.0% | 623.27M▼ 30.8% | 798.72M▲ 28.1% | 1.11B▲ 38.7% | 1.12B▲ 1.0% | 979.4M▼ 12.5% | 847.99M▲ 0% |
Equity Growth % | 3.1% | 9.43% | 22.88% | 24.03% | -30.84% | 28.15% | 38.71% | 1% | -12.47% | -54.32% |
Book Value per Share | 32.28 | 35.19 | 43.96 | 54.96 | 39.11 | 52.90 | 72.89 | 73.69 | 68.02 | 62.01 |
Total Shareholders' Equity | 540.35M | 591.33M | 726.61M | 901.2M | 623.27M | 798.72M | 1.11B | 1.12B | 979.4M | 847.99M |
Common Stock | 34.73M | 35.31M | 35.81M | 36.26M | 36.51M | 36.8M | 37.18M | 37.42M | 37.59M | 0 |
Retained Earnings | 1.04B | 1.23B | 1.43B | 1.72B | 1.97B | 2.2B | 2.45B | 2.72B | 2.96B | 3.01B |
Treasury Stock | -1.23B | -1.45B | -1.6B | -1.82B | -2.43B | -2.59B | -2.72B | -3.13B | -3.61B | 0 |
Accumulated OCI | 2.2M | 2.34M | 2.31M | 2.34M | 0 | 0 | 0 | 0 | 2.35M | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CHE Cash Flow Statement
Chemed Corporation (CHE) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 162.5M | 287.14M | 301.25M | 489.29M | 308.6M | 309.89M | 330.3M | 417.5M | 388.27M | 443.75M |
Operating CF Margin % | 9.75% | 16.11% | 15.54% | 23.53% | 14.43% | 14.51% | 14.59% | 17.17% | 15.35% | - |
Operating CF Growth % | 20.02% | 76.71% | 4.91% | 62.42% | -36.93% | 0.42% | 6.59% | 26.4% | -7% | 221.32% |
Net Income | 98.18M | 205.54M | 219.92M | 319.47M | 268.55M | 249.62M | 272.51M | 302M | 265.24M | 259.78M |
Depreciation & Amortization | 35.63M | 38.86M | 45.2M | 56.58M | 59.05M | 59.17M | 60.87M | 63.05M | 64.84M | 65.7M |
Stock-Based Compensation | 1.23M | 446K | 14.83M | 18.42M | 22.5M | 26.25M | 30.08M | 32.03M | 4.89M | 18.89M |
Deferred Taxes | 2.41M | 5.19M | -2.77M | 37.78M | -15.78M | -3.35M | -8.03M | -4.14M | -5.94M | 3.49M |
Other Non-Cash Items | 29.05M | 7.33M | 16.48M | 12.61M | 1.07M | 11.67M | 14.18M | 16.42M | 35.54M | 19.77M |
Working Capital Changes | -14.48M | 17.15M | 7.58M | 44.43M | -26.8M | -33.49M | -39.31M | 8.13M | 23.71M | 76.12M |
Change in Receivables | 1.07M | -5.57M | -19.25M | 12.77M | -8.43M | -2.41M | -41.49M | 10.68M | -11.6M | 22.93M |
Change in Inventory | 421K | -351K | -1.76M | 367K | -3.01M | -162K | -1.73M | 3.83M | 650K | 582K |
Change in Payables | 12.89M | 8.94M | 28.42M | 19.1M | 9.83M | 15.34M | -9.35M | -9.28M | -5.19M | 17.4M |
Cash from Investing | -67.61M | -105.22M | -190.76M | -61.56M | -57.76M | -59.4M | -60.64M | -143.91M | -59.34M | -83.45M |
Capital Expenditures | -64.3M | -52.87M | -53.02M | -58.83M | -58.67M | -57.33M | -56.85M | -49.53M | -62.8M | -66.63M |
CapEx % of Revenue | 3.86% | 2.97% | 2.74% | 2.83% | 2.74% | 2.69% | 2.51% | 2.04% | 2.48% | 2.62% |
Acquisitions | -4.72M | -53.18M | -138.01M | -3.6M | 0 | -3.53M | -3.99M | -97.4M | -225K | -20.61M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 1.42M | 824K | 272K | 871K | 918K | 1.45M | 206K | 3.02M | 3.68M | 3.79M |
Cash from Financing | -99.08M | -188.2M | -109.16M | -271.21M | -380.62M | -209.25M | -79.83M | -359.19M | -432.77M | -517.32M |
Debt Issued (Net) | -850K | -13.53M | 800K | -90M | 196.88M | -99.38M | -81.75M | -15.75M | 10.97M | 10.53M |
Equity Issued (Net) | -94.64M | -158.88M | -92.63M | -175.59M | -576.04M | -114.52M | -67.7M | -361.39M | -404.35M | -398.28M |
Dividends Paid | -17.37M | -18.66M | -19.79M | -21.08M | -22.02M | -22.02M | -23.5M | -27.09M | -31.7M | -32.54M |
Share Repurchases | -94.64M | -158.88M | -92.63M | -175.59M | -576.04M | -114.52M | -67.7M | -361.39M | -431.5M | -588.32M |
Other Financing | 13.79M | 2.87M | 2.46M | 15.46M | 20.55M | 26.66M | 93.13M | 45.04M | -7.69M | -97.03M |
Net Change in Cash | -4.19M▲ 0% | -6.29M▼ 50.2% | 1.33M▲ 121.1% | 156.52M▲ 11694.8% | -129.78M▼ 182.9% | 41.23M▲ 131.8% | 189.83M▲ 360.4% | -85.61M▼ 145.1% | -103.83M▼ 21.3% | -157.03M▲ 0% |
Free Cash Flow | 98.19M▲ 0% | 234.27M▲ 138.6% | 248.23M▲ 6.0% | 430.46M▲ 73.4% | 249.92M▼ 41.9% | 252.56M▲ 1.1% | 273.44M▲ 8.3% | 367.97M▲ 34.6% | 325.48M▼ 11.5% | 377.12M▲ 0% |
FCF Margin % | 5.89% | 13.14% | 12.8% | 20.7% | 11.68% | 11.83% | 12.08% | 15.13% | 12.86% | 14.84% |
FCF Growth % | 2.69% | 138.57% | 5.96% | 73.41% | -41.94% | 1.06% | 8.27% | 34.57% | -11.55% | 19.7% |
FCF per Share | 5.87 | 13.94 | 15.02 | 26.25 | 15.68 | 16.73 | 17.99 | 24.23 | 22.61 | 27.58 |
FCF Conversion (FCF/Net Income) | 1.66x | 1.40x | 1.37x | 1.53x | 1.15x | 1.24x | 1.21x | 1.38x | 1.46x | 1.45x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CHE Key Ratios
Chemed Corporation (CHE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 18.45% | 36.33% | 33.37% | 39.25% | 35.23% | 35.11% | 28.59% | 27.12% | 25.28% | 25.33% |
Return on Invested Capital (ROIC) | 13.59% | 27.98% | 23.95% | 32.29% | 28.78% | 27.33% | 25.92% | 26.42% | 23.7% | 22.83% |
Gross Margin | 30.97% | 31.13% | 31.85% | 33.73% | 35.98% | 35.84% | 35.28% | 35.14% | 29.97% | 22.49% |
Net Margin | 5.89% | 11.53% | 11.34% | 15.36% | 12.55% | 11.69% | 12.03% | 12.42% | 10.48% | 10.23% |
Debt / Equity | 0.19x | 0.15x | 0.30x | 0.15x | 0.52x | 0.31x | 0.14x | 0.13x | 0.16x | 0.28x |
Interest Coverage | 28.37x | 49.02x | 58.69x | 169.15x | 188.53x | 72.92x | 113.73x | 225.42x | 204.30x | 107.24x |
FCF Conversion | 1.66x | 1.40x | 1.37x | 1.53x | 1.15x | 1.24x | 1.21x | 1.38x | 1.46x | 1.45x |
Revenue Growth | 5.7% | 6.96% | 8.75% | 7.27% | 2.87% | -0.2% | 6.06% | 7.37% | 4.06% | 2.07% |
Related:CHE Dividend History·CHE Revenue History·CHE Price History·CHE P/E History·CHE Financial Ratios·CHE Institutional Holders
CHE SEC Filings & Documents
Chemed Corporation (CHE) SEC filings — annual & quarterly reports (10-K, 10-Q)
CHE Frequently Asked Questions
Chemed Corporation (CHE) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Chemed Corporation (CHE) reported $2.54B in revenue for fiscal year 2025. This represents a 743% increase from $301.2M in 1996.
Chemed Corporation (CHE) grew revenue by 4.1% over the past year. Growth has been modest.
Yes, Chemed Corporation (CHE) is profitable, generating $259.8M in net income for fiscal year 2025 (10.5% net margin).
Dividend & Returns
Yes, Chemed Corporation (CHE) pays a dividend with a yield of 0.50%. This makes it attractive for income-focused investors.
Chemed Corporation (CHE) has a return on equity (ROE) of 25.3%. This is excellent, indicating efficient use of shareholder capital.
Chemed Corporation (CHE) generated $377.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.